“…A total of 40 studies 14–21,24–27,29,31–33,35–38,40–42,45,46,48,50,52,54–65 were conducted in the U.S., and 13 studies 22,23,28,30,34,39,43,44,47,49,51,53,66 were conducted in other high-income countries. 13 The U.S. studies were distributed in the following geographic regions: Northeast, 15,18,24,37,38,46,50,52,58,62,63 Southeast, 17,18,26,27,55,64,65 Midwest, 14,16,25,36,42,45,54 Southwest, 19,20,29,33,35,56,59–61 and West. 21,29–32,40,41,48,57 There were non-U.S. studies from Japan 22 and Spain 23 for breast cancer; from Japan 28 and Canada 30 for cervical cancer; and from Netherlands, 34,39 France, 47,49,53 Hong Kong, 51 South Korea, 66 and Italy 43,44 for colorectal cancer.…”